Mar 24, 2025
First Patient Dosed in Immutep’s TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer
Mar 19, 2025
Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the European Lung Cancer Congress 2025
Jan 30, 2025
Immutep Quarterly Activities Report Q2 FY25
Jan 21, 2025
Patient Enrolment Completed for EFTISARC-NEO Phase II Trial
Jan 06, 2025
Patient Enrolment Completed for INSIGHT-003
